**Article impact statement**: Applying genetic, epigenetic, and microbial analyses to wildlife disease can inform active management and improve conservation outcomes.

Introduction {#cobi13083-sec-0030}
============

Integrative molecular approaches have yielded novel insights into human disease at a variety of scales. Independent and concurrent analysis of genetic, epigenetic, and commensal microbial diversity has elucidated proximate and ultimate drivers of disease state and transformed understanding of pathogenesis, transmission, and treatment (Pacis et al. [2014](#cobi13083-bib-0053){ref-type="ref"}; Hand [2016](#cobi13083-bib-0028){ref-type="ref"}). Similar analyses have only recently appeared within the context of wildlife disease and conservation science. We argue that adoption of diverse molecular methods in wildlife disease will provide more thorough appreciation of mechanisms that underlie host disease state and ultimately translate into more effective population monitoring, management, and conservation.

Wildlife disease can pose significant threats to human health, agricultural investment, and biodiversity conservation through the emergence of zoonoses, spillover to domestic livestock, and epizootic outbreaks (Daszak et al. [2000](#cobi13083-bib-0017){ref-type="ref"}). Initially, theoretical models suggested that disease‐mediated declines would halt transmission before host extinction could occur (Anderson & May [1979](#cobi13083-bib-0002){ref-type="ref"}). Although this is true for many pathogens with density‐dependent transmission, these well‐defined thresholds are often nonexistent for host--parasite systems with more nuanced transmission structures (Getz & Pickering [1983](#cobi13083-bib-0023){ref-type="ref"}). Complications include free‐living parasite stages, endangered hosts sharing parasites with abundant reservoir populations, and systems with frequency‐dependent transmission (Lafferty & Gerber [2002](#cobi13083-bib-0042){ref-type="ref"}; Lafferty et al. [2015](#cobi13083-bib-0041){ref-type="ref"}). Consequently, managers are tasked with mitigating wildlife disease in systems of varying complexity. Yet, elimination of harmful parasites remains elusive due to logistical challenges of reaching adequate proportions of wildlife, limited monetary and veterinary resources, and insufficient understanding of the numerous drivers underlying host disease state.

Environmental, immunological, behavioral, demographic, physiological, and molecular mechanisms contribute to the expression of host disease phenotype (Fig. [1](#cobi13083-fig-0001){ref-type="fig"}). Although many of these factors have been reviewed elsewhere, comprehensive understanding of molecular diversity in the context of wildlife disease is lacking. In many studies, *molecular diversity* is considered synonymous with *genetic diversity*, but this fails to consider 2 additional components critical to proper immune functioning in hosts: epigenetic gene regulation and commensal microbial communities.

![Factors affecting host disease state. Though presented as discrete categories, factors and subfactors often co‐occur and interact to form a complex web of connections driving host disease state across scales. See examples in Supporting Information for more information on factors, subfactors, and interactions.](COBI-32-798-g001){#cobi13083-fig-0001}

We reviewed recent advances in understanding the molecular underpinnings of wildlife disease and examined how molecular methods can inform management of disease dynamics operating across scales. We considered numerous examples to highlight questions that can be addressed with each molecular data type (i.e., parasite genetics, host genetics, epigenetic gene regulation, and commensal microbial variation). Two pathogens serve as our primary examples: devil facial tumor disease (DFTD) in Tasmanian devils (*Sarcophilus harrisii*) and chytridiomycosis in globally distributed amphibians (Table [1](#cobi13083-tbl-0001){ref-type="table"}). These diseases lie at the frontier of applying an integrative molecular approach to wildlife disease, and demonstrate the numerous insights that can be gleaned from adopting these methods.

###### 

Background information on devil facial tumor disease and chytridiomycosis

  Disease characteristic                         Devil facial tumor disease (DFTD)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Chytridiomycosis
  ---------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Host                                           Tasmanian devils (*Sarcophilus harrisii*)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Amphibians
  Infectious agent                               Transmissible cancer cells                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  *Batrachochytrium dendrobatidis* fungus
  Distribution                                   Tasmania, Australia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Global
  Transmission mode                              Allograft cells from contact with infected devils (especially biting)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Contact with infected individuals or local environment
  Pathology and conservation concern             DFTD is characterized by aggressive, ulcerated tumors on the face and mouth of infected devils. Infection and mortality rates are extremely high, with most deaths caused by starvation or metastases and organ failure occurring within 6 months of tumor development. Since first observation in 1996, DFTD has rapidly spread throughout the natural range of Tasmanian devils and remains the primary conservation concern threatening this iconic species. DFTD\'s status as a transmissible cancer renders it an ideal candidate for integrative molecular analyses, as these techniques can elucidate origin, transmission mode, and mechanisms of immune evasion.   Chytridiomycosis is an infectious skin disease implicated in driving amphibian declines on a global scale. Since formal description in 1997, chytridiomycosis has been documented in over 700 amphibian species with multiple fungal strains, interacting in a variety of environmental contexts. Perhaps unsurprisingly, it is characterized by high levels of variability in morbidity and mortality of hosts. Integrative molecular analyses of chytridiomycosis can address the molecular bases of host resistance and tolerance, fungal virulence, and environmental mediation of disease progression, and ultimately lead to novel management strategies.
  Disease caused by a similar infectious agent   Canine transmissible venereal tumor in dogs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 *Pseudogymnoascus destructans* causes white‐nose syndrome in bats
  Sources                                        Bender et al. [2014](#cobi13083-bib-0006){ref-type="ref"}; Pye et al. [2016](#cobi13083-bib-0056){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Van Rooij et al. [2015](#cobi13083-bib-0072){ref-type="ref"}; Lips [2016](#cobi13083-bib-0045){ref-type="ref"}
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Genetic Analyses of Wildlife Disease {#cobi13083-sec-0040}
====================================

Two central concepts have emerged in the history of genetic analyses and disease: parasite virulence and host resistance and tolerance are genetically based traits, and hosts and parasites are locked in a coevolutionary arms race, constantly evolving to obtain a mutational advantage over one another. Although this race is often asymmetrical due to the shorter generation time of pathogens, variation is the key driver of evolutionary change for both players. Thus, the application of molecular genetic techniques to the study of wildlife disease has typically focused on characterizing genetic diversity in parasites and their hosts and leveraging that information to discern selection on parasite transmission and host immunity. Technology has evolved from microsatellite markers through gene sequences to genomic data sets, but the core questions remain. It is the ability to address these questions that is considerably enhanced by large‐scale data sets and the increasing array of programs with which to analyze them.

Parasite Genetics {#cobi13083-sec-0050}
-----------------

The study of parasite genetics has moved from broad‐brush pathogen identification (McManus & Bowles [1996](#cobi13083-bib-0046){ref-type="ref"}) to more nuanced elucidation of complex transmission dynamics (Webster et al. [2016](#cobi13083-bib-0073){ref-type="ref"}). This is particularly important when managing endangered populations threatened by generalist parasites. Under these scenarios, multihost transmission can be the difference between population persistence and local extinction. For example, disease remains a primary threat to endangered Ethiopian wolves (*Canis simensis*) (Randall et al. [2004](#cobi13083-bib-0058){ref-type="ref"}; Gordon et al. [2015](#cobi13083-bib-0025){ref-type="ref"}). Though their population is too small to sustain pathogens such as canine distemper virus and rabies, the large population of dogs nearby is consistently identified as the source of disease outbreaks through viral sequencing. This renders both wolves and dogs critical targets for management.

Studies of parasite genetics can also be used to identify the subtle mechanisms underlying infection and *virulence* or damage to the host through parasite interactions (Schmid‐Hempel [2011](#cobi13083-bib-0064){ref-type="ref"}). These mechanisms can arise through mutation or horizontal gene transfer and facilitate processes such as toxin production, host cell invasion, and immune evasion that enable parasites to infect, propagate, transmit, and in some cases switch hosts (Hacker & Kaper [2000](#cobi13083-bib-0027){ref-type="ref"}; Geoghegan et al. [2016](#cobi13083-bib-0022){ref-type="ref"}). Avian influenza, for example, undergoes frequent mutation to sequentially infect the host respiratory tract and avoid sites of infection that limit transmission (Reperant et al. [2012](#cobi13083-bib-0061){ref-type="ref"}). For *Mycoplasma gallisepticum*, the bacterial pathogen that causes conjunctivitis in House Finches (*Haemorhous mexicanus*), quantitative genetic tools paired with disease phenotype data suggest rapid evolution of increased transmission potential and virulence upon emergence in a new host population (Hawley et al. [2013](#cobi13083-bib-0030){ref-type="ref"}).

By elucidating the specific molecular mechanisms underlying infection and virulence, one can pursue refined diagnostic tools, vaccination strategies, and therapeutic interventions (Johnston et al. [1999](#cobi13083-bib-0035){ref-type="ref"}). Genomic analyses comparing pathogenic *Batrachochytrium* spp., the causative agent of chytridiomycosis, with free‐living relatives, for example, reveal evolutionary adaptations for pathogenicity and infection strategies employed by different species (Farrer et al. [2017](#cobi13083-bib-0020){ref-type="ref"}). This represents a promising direction in chytridiomycosis research because parasite variability has been implicated in driving disease outcomes in hosts. Similar analyses of *Plasmodium* spp. suggest mechanisms of immune evasion in mosquito vectors (Molina‐Cruz et al. [2015](#cobi13083-bib-0048){ref-type="ref"}) and have identified loci associated with antimalarial drug resistance under positive selection (Shen et al. [2017](#cobi13083-bib-0067){ref-type="ref"}). Genetic tools have also located hotspots of polygenomic malaria infection, where hosts harbor multiple parasite strains simultaneously (Rice et al. [2016](#cobi13083-bib-0062){ref-type="ref"}). Considered together, this information enables better monitoring where malaria transmission and polygenomic infection rates are high and suggests possible molecular mechanisms for disease control.

To pursue these research and management goals, genetic analyses have been conducted on a wide range of parasite taxa (Supporting Information). Going forward, it is critical to focus on additional pathogens in multihost systems occurring in geographically diverse populations, particularly where spillover is likely. Further, it is important to perform comparative analyses in the contexts of host phenotype, genotype, and environment (Lazzaro & Little [2009](#cobi13083-bib-0043){ref-type="ref"}).

Host Genetics {#cobi13083-sec-0060}
-------------

Studies of host genetics tend to focus on resistance, tolerance, and diversity. *Resistance* can be defined as the ability to eliminate parasites from the host, whereas *tolerance* imposes limits on the parasite\'s negative effects (Best et al. [2008](#cobi13083-bib-0008){ref-type="ref"}, [2009](#cobi13083-bib-0009){ref-type="ref"}; Råberg et al. [2009](#cobi13083-bib-0057){ref-type="ref"}). Host fitness is intimately coupled with these traits and forms a significant component of their underlying mechanistic and molecular processes. In both cases, the prevailing paradigm is based on the assumption that genetic diversity at immune loci buffers hosts from disease risk. As such, demography resulting in genomic diversity loss (e.g., inbreeding) is often associated with increased likelihood of disease‐mediated population decline (Spielman et al. [2004](#cobi13083-bib-0070){ref-type="ref"}).

Early researchers examining host genetics in wildlife disease adopted a broad definition of *genetic diversity*. Employing neutral microsatellite markers, they calculated summary statistics to determine whether host genetics correlated with disease state. Although many reported significant relationships (Coltman et al. [1999](#cobi13083-bib-0016){ref-type="ref"}), others failed to identify strong associations between neutral diversity and disease (Schwensow et al. [2007](#cobi13083-bib-0065){ref-type="ref"}). This led many to question the efficacy of using neutral markers as a proxy for genome‐wide variation (Väli et al. [2008](#cobi13083-bib-0071){ref-type="ref"}) and ultimately shifted the field toward a more targeted immunogenetic approach.

In vertebrate systems, the major histocompatibility complex (MHC) dominated the literature. Critical to adaptive immunity, this hypervariable gene family encodes for MHC molecules that bind to antigens and display them on cell surfaces to initiate an immune response. This renders MHC variation a convenient target for candidate gene approaches. For example, analyses of Tasmanian devils threatened by DFTD suggest that low MHC diversity in hosts may provide means of immune evasion for this transmissible cancer (Siddle et al. [2007](#cobi13083-bib-0068){ref-type="ref"}). Similar analyses in amphibians show associations between MHC diversity and survival in frogs experimentally infected with the pathogenic fungus *Batrachochytrium dendrobatidis* (Bd) and host species known to be Bd resistant (Fu & Waldman [2017](#cobi13083-bib-0021){ref-type="ref"}).

The MHC‐based explorations of host disease state consider only one aspect of immunity, however. Many other genes (e.g., Toll‐like receptors) also aid host defense (Acevedo‐Whitehouse & Cunningham [2006](#cobi13083-bib-0001){ref-type="ref"}). Further, specific genes often associate with disease state more strongly than summary statistics of genetic variation (Bateson et al. [2016](#cobi13083-bib-0004){ref-type="ref"}); thus, treating MHC diversity as a proxy for larger scale immunogenetic variation may eventually prove too reductionist.

Genomic methods are increasingly used by conservation scientists to pursue more comprehensive analyses. Since publication of the first human genome, technological advances have rendered whole genome sequencing accessible for wildlife studies. Even when whole genomes are unavailable, restriction enzyme‐based methods rapidly and affordably generate genome‐wide data (Davey & Blaxter [2010](#cobi13083-bib-0018){ref-type="ref"}). For example, genomic analyses confirmed low levels of standing variation in Tasmanian devils, identified geographic structuring of host populations, enabled reconstruction of DFTD emergence and transmission pathways, and supported allograft transmission of this contagious cancer (Murchison et al. [2012](#cobi13083-bib-0052){ref-type="ref"}; Grueber et al. [2015](#cobi13083-bib-0026){ref-type="ref"}; Morris et al. [2015](#cobi13083-bib-0050){ref-type="ref"}; Hendricks et al. [2017](#cobi13083-bib-0031){ref-type="ref"}). Although in accordance with earlier MHC‐based studies, genomic analyses enabled deeper understanding of the roles host and cancer genomics play in DFTD pathogenesis. They additionally positioned genetic diversity maintenance as a top conservation priority for wild and captive devil management.

We hope that more systems will benefit from similarly comprehensive analyses. Although the trend toward genome‐level data comes with inherent difficulties, it provides critical insight into complex disease dynamics. By integrating the study of parasite and host genomics, wildlife managers can leverage better understanding of parasite virulence, transmission, and host disease state toward more effective prevention and management.

Host Gene Regulation in Immunity {#cobi13083-sec-0070}
================================

For the immune system to properly function, genes must produce their corresponding antigen binding, recognition, and signaling proteins. Gene regulatory variation therefore arises as another contributor to host disease state. If an underlying genotype for host immunity is transcriptionally silenced, infection becomes likely. For example, suppression of inflammatory response genes in bats may allow them to asymptomatically harbor viruses that are highly damaging to nonvolant mammals (Brook & Dobson [2015](#cobi13083-bib-0011){ref-type="ref"}; Banerjee et al. [2017](#cobi13083-bib-0003){ref-type="ref"}).

Epigenetic mechanisms (e.g., DNA methylation, histone modification, etc.) can alter the expression of immune genes in response to environmental stimuli, thereby inducing or preventing an immune response (Morandini et al. [2016](#cobi13083-bib-0049){ref-type="ref"}). Thus, effective immunity requires action from both genetic and epigenetic dimensions of the host genome: the genetic capacity to recognize and respond to a diverse array of parasites, the concerted expression of those genes, and the ability to overcome immune escape efforts.

The functional link between epigenetics and immunity is a burgeoning field. Although many studies focus on tumor growth, autoimmune disorders, and developmental changes, increasing attention is being paid to epigenetic mechanisms operating in infectious disease (Pacis et al. [2014](#cobi13083-bib-0053){ref-type="ref"}; Zhao et al. [2015](#cobi13083-bib-0075){ref-type="ref"}). From the perspective of resistant hosts, fine‐tuned regulation of immune genes and tissues targeted by pathogens may enable early detection and eradication of infecting parasites, as seen in some frogs experimentally infected with Bd (Ellison et al. [2014](#cobi13083-bib-0019){ref-type="ref"}). Where tolerance is preferred, suppression of these genes and their resultant processes (e.g., strong inflammatory responses) may ultimately lessen morbidity, as seen in bats infected with viruses (Banerjee et al. [2017](#cobi13083-bib-0003){ref-type="ref"}).

Yet, it often appears that epigenetic alterations worsen disease outcomes for hosts. In accordance with the coevolutionary arms race, many parasites manipulate host epigenomes to facilitate immune evasion and within‐host proliferation (Paschos & Allday [2010](#cobi13083-bib-0054){ref-type="ref"}). For example, *Leishmania* protozoans are hypothesized to alter DNA methylation patterns in macrophages to downregulate host defenses and promote parasite survival (McMaster et al. [2016](#cobi13083-bib-0047){ref-type="ref"}). Similarly, infection with influenza viruses and coronaviruses may induce histone modifications that alter immune signaling in favor of infecting parasites (Schäfer & Baric [2017](#cobi13083-bib-0063){ref-type="ref"}). Such phenomena remain active areas of research, as scientists seek to uncover the diverse mechanisms used by parasites to circumvent host immunity (Supporting Information).

Within wildlife systems, the field of ecological epigenetics has focused primarily on changes induced by behavior, diet, and environmental conditions. Only a few researchers have linked these changes to immune processes (Isaksson [2015](#cobi13083-bib-0033){ref-type="ref"}), and fewer still have examined differences in gene regulation between host populations. In 1 example, Ellison et al. ([2014](#cobi13083-bib-0019){ref-type="ref"}) compared transcriptome data from 4 sympatric frog species with different Bd susceptibility. When exposed to a pathogenic strain of Bd, resistant species exhibited downregulation of skin inflammatory pathways and upregulation of genes pertaining to skin‐barrier integrity and cell‐mediated immune responses. These patterns suggests that resistant hosts maintain skin and immune functioning during infection. This contrasts susceptible species, which often succumb to immunosuppression and disease‐mediated disruption of the skin barrier. Together, these results reveal important processes involved in chytridiomycosis morbidity and mortality across species.

Perhaps the strongest example of an integrative genomic, transcriptomic, and epigenetic approach to understanding disease pathogenesis occurs at the intersection of cancer and infectious disease with DFTD. Although genomic analyses revealed insights about host diversity and disease transmission, they have not elucidated specific mechanisms underlying emergence and immune evasion of this transmissible cancer. To address these questions, Murchison et al. ([2010](#cobi13083-bib-0051){ref-type="ref"}) considered functional variation alongside traditional genetic markers. Host and parasite genetics confirmed that tumors were genetically distinct from hosts and clonal in origin. Analyses of devil and tumor transcriptomes suggest that DFTD first arose in a mutated Schwann cell. Even though these cells function in local immunity, the Schwann cell origin of DFTD does not sufficiently explain the capacity of tumor cells to evade the immune system. More likely mechanisms appeared in analysis of expression profiles, which revealed upregulation in molecules associated with immune evasion and downregulation in molecules associated with tumor suppression. Considered alongside MHC‐based and genomic analyses (Grueber et al. [2015](#cobi13083-bib-0026){ref-type="ref"}; Morris et al. [2015](#cobi13083-bib-0050){ref-type="ref"}), it seems that low immunogenetic diversity in hosts decreases the immune system\'s probability of detecting tumors that fail to display MHC class I molecules on their cell surfaces (Siddle et al. [2007](#cobi13083-bib-0068){ref-type="ref"}, [2013](#cobi13083-bib-0069){ref-type="ref"}). This failure appears to result from epigenetic changes that induce downregulation of antigen‐processing genes in cancerous cells, which then allows tumor cells to slip under the immune system\'s radar. Critically, this may be reversible through epigenetic or immunological manipulation, which suggests a promising new direction for treatment (Siddle et al. [2013](#cobi13083-bib-0069){ref-type="ref"}).

In the case of DFTD, chytridiomycosis, and other wildlife diseases, analyses of gene regulation provide a powerful tool for identifying mechanisms underlying pathogenesis and pursuing novel targets for treatment (Kungulovski & Jeltsch [2016](#cobi13083-bib-0040){ref-type="ref"}). Yet, questions remain about the factors that operate alongside hosts and parasites to induce these changes. Recent evidence suggests that epigenetic mechanisms interact with commensal microbial communities inhabiting hosts, thus participating in regulatory cross‐talk between the immune system, epigenome, and microbiome (Levy et al. [2015](#cobi13083-bib-0044){ref-type="ref"}; Celluzzi & Masotti [2016](#cobi13083-bib-0013){ref-type="ref"}). The importance of this cross‐talk has yet to be elucidated, but mounting evidence suggests that a more complex understanding of immune regulation is needed.

Commensal Microbes and Dysbiosis {#cobi13083-sec-0080}
================================

Studies of humans and model systems increasingly extol the importance of microbiomes in immunity. Commensal microbes have been implicated in developing the host immune system, shielding hosts from infection by competing with invaders, regulating immune responses through altered gene expression and immune signaling, and aiding resolution of responses once parasites are cleared (Supporting Information). Extreme examples are the fungal microbiomes of many plants that have self‐organized into symbiotic immune systems that possess all the classic features of vertebrate immune systems (e.g., self‐ and nonself recognition and short‐ and long‐term memory) (Berendsen et al. [2012](#cobi13083-bib-0007){ref-type="ref"}).

Unlike other aspects of host biology, microbial communities are both stable and flexible, rendering them particularly useful to immunity. Core microbiota, or resident commensals that consistently colonize certain body sites, are largely determined by host genetics (Goodrich et al. [2014](#cobi13083-bib-0024){ref-type="ref"}). Healthy community composition is often taxon specific and putatively results from long‐term coevolution (Colston & Jackson [2016](#cobi13083-bib-0015){ref-type="ref"}). Transient and temporary resident microbes primarily derive from environmental and behavioral sources (Candela et al. [2012](#cobi13083-bib-0012){ref-type="ref"}). These can rapidly change to reflect different external conditions or parasitic infections and may even function in larger scale adaptation of hosts (Shapira [2016](#cobi13083-bib-0066){ref-type="ref"}).

In the absence of infection, commensal microbial communities aid homeostasis and are critical to host defense (Honda & Littman [2016](#cobi13083-bib-0032){ref-type="ref"}). Yet, microbes do not present an impenetrable front. Termed *dysbiosis*, disruption of healthy microbial communities is often associated with autoimmunity and disease pathogenesis (Petersen & Round [2014](#cobi13083-bib-0055){ref-type="ref"}). As a result, microbial analyses of human diseases have skyrocketed in the last decade as researchers seek to elucidate mechanisms underlying pathology and design novel treatments (Knight [2015](#cobi13083-bib-0036){ref-type="ref"}).

The need for studies examining the role of microbial communities in wildlife disease is increasingly recognized (Redford et al. [2012](#cobi13083-bib-0060){ref-type="ref"}). Many primarily seek to characterize microbiome structure in healthy individuals. For example, Cheng et al. ([2015](#cobi13083-bib-0014){ref-type="ref"}) sequenced microbial communities from wild and captive Tasmanian devils and noted distinct differences between them. This establishes a baseline for comparison with communities disrupted by captivity and DFTD. In other systems, such as chytridiomycosis, research has moved away from descriptive studies toward manipulative experiments seeking novel treatment options. Many amphibian species naturally harbor skin bacteria known to secrete metabolites harmful to Bd. Commensal microbial communities have therefore been associated with differing disease outcomes in host populations (Jani et al. [2017](#cobi13083-bib-0034){ref-type="ref"}). In an effort to commandeer this phenomenon for disease management, treatment of *Rana muscosa* with Bd*‐*resistant bacteria drastically decreased mortality in experimental trials (Harris et al. [2009](#cobi13083-bib-0029){ref-type="ref"}). Similar results were reported for experimental manipulations of *Anaxyrus boreas* microbial communities, where the loss of Bd‐inhibitory bacteria increased infection rates and the application of resistant bacteria increased survival (Kueneman et al. [2016](#cobi13083-bib-0038){ref-type="ref"}). However, probiotic bioaugmentation may not be universally applicable as frog species harbor unique communities that differ in response to manipulation (Kueneman et al. [2014](#cobi13083-bib-0037){ref-type="ref"}; Küng et al. [2014](#cobi13083-bib-0039){ref-type="ref"}). In the case of probiotic‐resistant species, community composition may act as a sentinel for estimating susceptibility across populations (Becker et al. [2015](#cobi13083-bib-0005){ref-type="ref"}). By focusing on community structure and function, adoption of a multiomic approach may mitigate this difficulty through design of more effective taxon‐specific probiotic therapies (Rebollar et al. [2016](#cobi13083-bib-0059){ref-type="ref"}).

Applying an Integrative Molecular Approach to Conservation {#cobi13083-sec-0090}
==========================================================

When examined in isolation, genetic, epigenetic, and microbial variation can provide key information about wildlife disease ecology that informs conservation. Although implementing these methods in wildlife comes with the inherent challenges of limited sampling opportunity, lack of reference genomes for nonmodel organisms, and high start‐up costs of learning new laboratory and analytical techniques, it remains a worthwhile and versatile endeavor. Depending on the resources available, ability to collect samples, complexity of the host--parasite system, and questions most relevant to effective conservation, managers can pick and choose the methods that best address their needs (Fig. [2](#cobi13083-fig-0002){ref-type="fig"}). Further, decreased sequencing costs and increasingly user‐friendly analytical pipelines have rendered these methods accessible to studies of nonmodel organisms.

![Steps in the application of molecular methods to wildlife disease. In step 1, the question of interest must be identified. In step 2, the molecular method selected needs to address the chosen question. In step 3, samples need to fit the selected method and financial and logistical constraints of sampling the host--parasite system. In step 4, the molecular dataset must be appropriate for addressing the question with the collected samples. For complex systems characterized by multiple questions, relevant methods are combined to adopt an integrative molecular approach. See Supporting Information for case studies in which molecular techniques informed management of wildlife disease.](COBI-32-798-g002){#cobi13083-fig-0002}

When multiple questions arise and resources allow, applying an integrative molecular approach represents an exciting new frontier in wildlife disease ecology. Concurrent examination of interconnected factors within molecular diversity can elucidate patterns and processes relevant to complex wildlife disease systems. As evidenced in case studies of DFTD and chytriodiomycosis, analysis of genetic, gene regulatory, and microbial variation provides important insight into pathology, transmission dynamics, and novel avenues of treatment. For DFTD, genetic and transcriptomic analyses were needed to distinguish host from parasite, confirm allograft transmission and Schwann cell origin of the disease, and discover means of immune evasion through suppression of immune signaling amid minimal immunogenetic diversity in hosts. These insights have since informed management strategies, including ongoing treatment development and management of captive insurance populations (Pye et al. [2016](#cobi13083-bib-0056){ref-type="ref"}). In the case of chytriodiomycosis, genetic and transcriptomic analyses have furthered understanding of immune processes involved in species‐specific resistance to fungal infection, and microbial analyses have provided promising new treatment options through bioaugmentation with naturally Bd*‐*resistant microbes (Bletz et al. [2013](#cobi13083-bib-0010){ref-type="ref"}; Woodhams et al. [2016](#cobi13083-bib-0074){ref-type="ref"}).

Overall, application of molecular methods will enable more effective monitoring and management of at‐risk populations. Depending on questions and data types examined (Fig. [2](#cobi13083-fig-0002){ref-type="fig"}), understanding of wildlife disease prevalence, pathology, and persistence can be improved. Parasite genetics can refine diagnostic techniques, reconstruct transmission pathways, and identify genes underlying virulence. Similar analyses in hosts can characterize host population structure, patterns of immunogenetic diversity, and specific genes associated with resistance and tolerance strategies. Further examination of gene regulatory diversity can identify specific mechanisms underlying successful parasite invasion and host morbidity that may serve as targets for epigenetic intervention. Finally, commensal microbial analyses can elucidate patterns of dysbiosis associated with host disease state and suggest probiotic bioaugmentation as a novel treatment strategy. Especially when considered alongside other drivers of disease state (Fig. [1](#cobi13083-fig-0001){ref-type="fig"}), molecular analyses present innumerable opportunities to advance management of wildlife disease and mitigate threats posed to human and domestic animal health, agricultural systems, and wildlife populations. From examination of the human literature, it is evident that the technology for molecular analyses exists. The urgency of many conservation problems suggests that it is time these methods are applied to studies of wildlife disease.

Supporting information
======================
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Tables containing additional citations serving as examples of factors affecting host susceptibility (Appendix S1), genetic analyses of parasites (Appendix S2), epigenetic, microbial, and integrative molecular analyses in human and model systems (Appendix S3), and molecular analyses informing wildlife conservation (Appendix S4) are available online. The authors are solely responsible for the content and functionality of these materials. Queries (other than absence of the material) should be directed to the corresponding author.
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